|
Full Conference Audio Recordings - Plus Slides
Available on USB Flash Drive
This package features audio recordings of all sessions recorded exactly as is happened at the Massachusetts General Hospital Psychiatry Academy "Substance Use Disorders: A Comprehensive Review and Update 2020" Conference, held February 16-19, 2020.
Includes MP3 files of every session. Listen on your computer or fill your iPod or favorite MP3 player with all the live audio from every session. This package allows you to review presentations and is a lasting valuable resource.
BONUS: Also includes slides of sessions in PDF format. |
INCLUDES ALL OF THE PRESENTATIONS FROM THE CONFERENCE:
Item |
Monday, February 17, 2020 |
|
|
Module Topic 1: Empirically Based Methodologies |
|
33321 |
Motivational Interviewing |
John F. Kelly, PhD |
33322 |
CBT |
John F. Kelly, PhD |
33323 |
Harm Reduction |
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP |
33324 |
Empirically Based Methodologies Panel Discussion |
Timothy E. Wilens, MD; John F. Kelly, PhD; Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP |
|
Module Topic 2: Recovery Oriented |
|
33325 |
Self-Help Treatments |
John F. Kelly, PhD |
33326 |
Screening |
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP |
33327 |
Treating Addiction as a Chronic Disease |
Jessica Gray, MD |
33328 |
Emergency Room Assessment of Addiction |
Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP |
33329 |
Recovery Oriented Panel Discussion |
Timothy E. Wilens, MD; John F. Kelly, PhD; Jessica Gray, MD; Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP |
|
Module Topic 3: Pharmacotherapy I |
|
33330 |
Alcohol |
Laura G. Kehoe, MD, MPH, FASAM |
33331 |
Methamphetamine, Cocaine, Stimulants |
Timothy E. Wilens, MD |
33332 |
Pharmacotherapy I Panel Discussion |
John F. Kelly, PhD; Laura G. Kehoe, MD, MPH, FASAM; Timothy E. Wilens, MD |
|
Module Topic 4: Opioid |
|
33333 |
Overview of Opioid Use Disorder |
Laura G. Kehoe, MD, MPH, FASAM |
33334 |
Buprenorphine 101 |
Laura G. Kehoe, MD, MPH, FASAM |
33335 |
Naltrexone Intramuscular & Methadone |
Laura G. Kehoe, MD, MPH, FASAM |
33336 |
Pain |
Jessica Gray, MD |
33337 |
Pregnancy |
Jessica Gray, MD |
33338 |
Opioid Panel Discussion |
Timothy E. Wilens, MD; Laura G. Kehoe, MD, MPH, FASAM; Jessica Gray, MD |
Item |
Tuesday, February 18, 2020 |
|
|
Module Topic 5: Neuroscience |
|
33339 |
Neurobiology of Addiction |
Timothy E. Wilens, MD |
33340 |
Genetics of Substance Use Disorders |
Robert R. Althoff, MD, PhD |
33341 |
Evolutionary Theories of Substance Use |
David H. Rubin, MD |
|
Module Topic 6: Marijuana and Synthetics |
|
33342 |
Neurobiology and Pharmacology of Marijuana |
Timothy E. Wilens, MD |
33343 |
Clinical Management |
Robert R. Althoff, MD, PhD |
33344 |
Medical Marijuana |
Timothy E. Wilens, MD |
33345 |
Marijuana and the Developing Brain |
Timothy E. Wilens, MD |
33346 |
Marijuana and Synthetics Panel Discussion |
David H. Rubin, MD; Timothy E. Wilens, MD; Robert R. Althoff, MD, PhD |
33347 |
Synthetics and Designer Drugs |
Timothy E. Wilens, MD |
Item |
Wednesday, February 20, 2019 |
|
|
Module Topic 7: Comorbidity |
|
33348 |
Mood Disorders |
Shamim H. Nejad, MD |
33349 |
Anxiety Disorders |
Shamim H. Nejad, MD |
33350 |
Comorbidity Question & Answer Session |
Shamim H. Nejad, MD |
|
Module Topic 8: Pharmacotherapy II |
|
33351 |
Complex Alcohol Withdrawal |
Shamim H. Nejad, MD |
33352 |
Nicotine |
Shamim H. Nejad, MD |
33353 |
Sedatives and Hypnotics |
Robert R. Althoff, MD, PhD |
33354 |
Pharmacotherapy II Panel Discussion |
David H. Rubin, MD; Shamim H. Nejad, MD; Robert R. Althoff, MD, PhD |
|